1. Home
  2. DERM vs JHI Comparison

DERM vs JHI Comparison

Compare DERM & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DERM

Journey Medical Corporation

HOLD

Current Price

$6.00

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Logo John Hancock Investors Trust

JHI

John Hancock Investors Trust

HOLD

Current Price

$13.20

Market Cap

116.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
JHI
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.3M
116.0M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
DERM
JHI
Price
$6.00
$13.20
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.67
N/A
AVG Volume (30 Days)
266.2K
23.6K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
34.72
N/A
EPS
N/A
N/A
Revenue
$61,858,000.00
N/A
Revenue This Year
$39.72
N/A
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$12.50
52 Week High
$9.56
$14.51

Technical Indicators

Market Signals
Indicator
DERM
JHI
Relative Strength Index (RSI) 52.77 46.93
Support Level $5.77 $12.93
Resistance Level $6.59 $13.56
Average True Range (ATR) 0.31 0.12
MACD -0.02 0.00
Stochastic Oscillator 33.33 46.19

Price Performance

Historical Comparison
DERM
JHI

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About JHI John Hancock Investors Trust

John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others. The company's portfolio includes Corporate Bonds, Term Loans, U.S Government Agency, and Others.

Share on Social Networks: